Every day, patients navigating today’s healthcare environment face challenges that can prevent them from accessing their specialty medications. […]
High-Touch Support: Real Value for Manufacturers and Patients
Category: Article
Category Added in a WPeMatico Campaign
Empowering Manufacturers: Decoding Maximizers and Accumulators for Fair Healthcare Access
Pharmaceutical manufacturers continue to sponsor copay programs to help patients afford life-saving medications, while payers continue to respond with new varieties of copay accumulators and maximizers that shift the financial burden to patients and manufacturers. It’s a vicious cycle that jeopardizes health outcomes. […]
Are You Maximizing Hub Value? Dig Deeper into the Impact of Patient-Centric Solutions
The use of specialty therapeutics is rapidly rising, creating significant growth opportunities for pharmaceutical manufacturers that are positioned to deliver strong value to patients and other stakeholders. Yet, the ability to meet patient needs throughout their care journey isn’t without its challenges. These challenges place greater demands on both pharmaceutical manufacturers and the Digital Hub providers they partner with to support their patient services programs. […]
Survey Results Reveal Insights on Impacting Therapy Initiation
The success of specialty therapeutics often hinges on navigating a complex, multi-step process to initiate patients on a new therapy. Without ensuring a positive experience from the outset, there is a significant risk that patients may not engage with, or adhere to, the treatment plan. Merely confirming a patient’s benefits and providing a prescription are insufficient to establish a solid foundation for patient initiation. […]
Is Your Hub Implementation Setting the Stage for Patient Support Program Success?
When a manufacturer launches a patient support program, choosing the right Hub provider to partner with is only part of the equation. From there, getting the Hub implementation right is just as important. A smooth start sets the stage for the entire patient experience—bolstering a manufacturer’s ability to support drug initiation, adherence, and positive health outcomes. […]
Core Drivers in Manufacturers’ Digital Hub Decisions
Digital Hubs are vital for helping pharmaceutical manufacturers drive strong initiation, adherence, and persistence for specialty therapies to help patients achieve positive health outcomes. But choosing the Digital Hub provider that is the best fit for particular therapy is an intricate undertaking. […]
How to Keep Your Copay Program Agile in an Evolving Payer Landscape
With healthcare costs skyrocketing and inflation straining household budgets, many patients are finding it more challenging than ever to pay for their specialty medications. Copay programs can go a long way toward helping patients afford life-altering therapies, but these options are under greater pressure in today’s evolving payer landscape. […]
What Do Top Manufacturers Say about the Future of Hubs?
If you’re a specialty pharmaceutical manufacturer preparing to launch a new therapy, establishing a patient program that supports the patient’s journey from end to end—from therapy initiation to positive health outcomes—is critical. So much so, it may be the difference between success and failure for the program, and for the therapeutic benefit of your brand. […]
How to Engage Patients Throughout the Therapy Journey
Taking specialty medication is not usually as easy as taking a once daily pill. Rather, many specialty products require careful patient focus on how they should be handled and administered properly. Even when patients are prescribed a daily oral specialty medication, many of those oral medications come with a toxicity profile, or even a food requirement that must be carefully understood. For some specialty medications, patients may need to arrange travel and overnight stays if they’re receiving treatment administered at a location that might not be nearby. […]
Analytics and Data Integration: Changing the Game for Digital Hubs
Supporting patients throughout the entire specialty therapy journey is essential to achieving positive health outcomes. More and more, data is what lies at the heart of this critical objective. As CareMetx’s latest report, The Evolving Landscape of Digital Hubs revealed, the ability to integrate data seamlessly, then analyze and report on it effectively is critical for manufacturers that rely on digital hubs to support their drug programs. […]